Literature DB >> 25700526

Chronic obstructive pulmonary disease lung microbiota diversity may be mediated by age or inhaled corticosteroid use.

Alexa A Pragman1, Hyeun Bum Kim2, Cavan S Reilly3, Christine Wendt4, Richard E Isaacson5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25700526      PMCID： PMC4390650          DOI： 10.1128/JCM.03320-14

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  3 in total

1.  Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Authors:  Yvonne J Huang; Sanjay Sethi; Timothy Murphy; Snehal Nariya; Homer A Boushey; Susan V Lynch
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

2.  Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease.

Authors:  Marian Garcia-Nuñez; Laura Millares; Xavier Pomares; Rafaela Ferrari; Vicente Pérez-Brocal; Miguel Gallego; Mateu Espasa; Andrés Moya; Eduard Monsó
Journal:  J Clin Microbiol       Date:  2014-09-24       Impact factor: 5.948

3.  The lung microbiome in moderate and severe chronic obstructive pulmonary disease.

Authors:  Alexa A Pragman; Hyeun Bum Kim; Cavan S Reilly; Christine Wendt; Richard E Isaacson
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240
  3 in total
  8 in total

1.  Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Authors:  Charlie Strange; Robert M Senior; Frank Sciurba; Scott O'Neal; Alison Morris; Stephen R Wisniewski; Russell Bowler; Harry S Hochheiser; Michael J Becich; Yingze Zhang; Joseph K Leader; Barbara A Methé; Naftali Kaminski; Robert A Sandhaus
Journal:  Ann Am Thorac Soc       Date:  2015-10

2.  Study of the Lung Microbiome. Have We Reached the End of the Beginning?

Authors:  Alison Morris; Sonia C Flores
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

3.  Differences of the Nasal Microbiome and Mycobiome by Clinical Characteristics of COPD Patients.

Authors:  Maura Alvarez Baumgartner; Chengchen Li; Thomas M Kuntz; Lina Nurhussien; Andrew J Synn; Wendy Y Sun; Jennifer E Kang; Peggy S Lai; Jeremy E Wilkinson; Mary B Rice
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

4.  Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?

Authors:  Shivani Singh; Alexa A Pragman; Leopoldo N Segal
Journal:  Am J Respir Crit Care Med       Date:  2021-11-15       Impact factor: 30.528

5.  The sputum microbiome is distinct between COPD and health, independent of smoking history.

Authors:  Koirobi Haldar; Leena George; Zhang Wang; Vijay Mistry; Mohammadali Yavari Ramsheh; Robert C Free; Catherine John; Nicola F Reeve; Bruce E Miller; Ruth Tal-Singer; Adam J Webb; Anthony J Brookes; Martin D Tobin; Dave Singh; Gavin C Donaldson; Jadwiga A Wedzicha; James R Brown; Michael R Barer; Christopher E Brightling
Journal:  Respir Res       Date:  2020-07-14

6.  Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study.

Authors:  Alexa A Pragman; Katherine A Knutson; Trevor J Gould; Richard E Isaacson; Cavan S Reilly; Chris H Wendt
Journal:  Respir Res       Date:  2019-06-07

7.  Richness of sputum microbiome in acute exacerbations of eosinophilic chronic obstructive pulmonary disease.

Authors:  Yu-Jing Qi; Xue-Jiao Sun; Zhe Wang; Yan-Fei Bin; Ying-Hua Li; Xiao-Ning Zhong; Jing Bai; Jing-Min Deng; Zhi-Yi He
Journal:  Chin Med J (Engl)       Date:  2020-03-05       Impact factor: 2.628

8.  Microbial and host immune factors as drivers of COPD.

Authors:  Moana Mika; Izabela Nita; Laura Morf; Weihong Qi; Seraina Beyeler; Eric Bernasconi; Benjamin J Marsland; Sebastian R Ott; Christophe von Garnier; Markus Hilty
Journal:  ERJ Open Res       Date:  2018-07-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.